Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly K Filipski

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Lung Cancer|January 1, 2017
Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans AffairsJulie A Lynch, Brygida Berse, Danielle Chun, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
Population-based utilization and costs associated with tyrosine kinase inhibitors for first-line treatment of chronic myelogenous leukemia among elderly patientsDonna R Rivera, Lindsey Enewold, Michael J Barrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2015
Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored WorkshopDanielle M Carrick, Anil K Chaturvedi, Meredith S Shiels, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 24, 2014
An overview of recommendations and translational milestones for genomic tests in cancerChristine Q Chang, Sharna R Tingle, Kelly K Filipski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Cisplatin-induced downregulation of OCTN2 affects carnitine wastingCynthia S Lancaster, Chaoxin Hu, Ryan M Franke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Interaction of imatinib with human organic ion carriersShuiying Hu, Ryan M Franke, Kelly K Filipski, et al.
Familial Cancer|September 4, 2016
BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelinesDanielle S Chun, Brygida Berse, Vickie L Venne, et al.
Journal of the National Cancer Institute|December 8, 2021
Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting ReportMichelle A Mollica, Ashley Wilder Smith, Emily Tonorezos, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2021
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicineAmalia M Issa, Bruce Carleton, Tobias Gerhard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2021
Epidemiologic Research of Rare Cancers: Trends, Resources, and ChallengesLisa Gallicchio, Danielle L Daee, Melissa Rotunno, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Lung Cancer|January 1, 2017
Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans AffairsJulie A Lynch, Brygida Berse, Danielle Chun, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
Population-based utilization and costs associated with tyrosine kinase inhibitors for first-line treatment of chronic myelogenous leukemia among elderly patientsDonna R Rivera, Lindsey Enewold, Michael J Barrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2015
Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored WorkshopDanielle M Carrick, Anil K Chaturvedi, Meredith S Shiels, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 24, 2014
An overview of recommendations and translational milestones for genomic tests in cancerChristine Q Chang, Sharna R Tingle, Kelly K Filipski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Cisplatin-induced downregulation of OCTN2 affects carnitine wastingCynthia S Lancaster, Chaoxin Hu, Ryan M Franke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Interaction of imatinib with human organic ion carriersShuiying Hu, Ryan M Franke, Kelly K Filipski, et al.
Familial Cancer|September 4, 2016
BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelinesDanielle S Chun, Brygida Berse, Vickie L Venne, et al.
Journal of the National Cancer Institute|December 8, 2021
Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting ReportMichelle A Mollica, Ashley Wilder Smith, Emily Tonorezos, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2021
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicineAmalia M Issa, Bruce Carleton, Tobias Gerhard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2021
Epidemiologic Research of Rare Cancers: Trends, Resources, and ChallengesLisa Gallicchio, Danielle L Daee, Melissa Rotunno, et al.
Pageof 3